Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
2 Visualizzazioni
administrator
08/04/23
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
Mostra di più
Commenti su Facebook
Nessun commento trovato